Intracellular Glutathione Determines Bortezomib Cytotoxicity in Multiple Myeloma Cells

Blood Cancer Journal - United States
doi 10.1038/bcj.2016.56
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Curcumin in Combination With Bortezomib Synergistically Induced Apoptosis in Human Multiple Myeloma U266 Cells

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Bortezomib for the Treatment of Multiple Myeloma Patients

Health Technology Assessment
MedicineHealth Policy
2009English

Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs

International Journal of Molecular Medicine
MedicineGenetics
2011English

Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma

Core Evidence
MedicineReviewsReferencesPharmacology
2006English

Signaling Mechanisms of Bortezomib in TRAF3-deficient Mouse B Lymphoma and Human Multiple Myeloma Cells

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Blood Distribution of Bortezomib and Its Kinetics in Multiple Myeloma Patients

Clinical Biochemistry
MedicineClinical Biochemistry
2014English

Depletion of Intracellular Glutathione and Increased Lipid Peroxidation Mediate Cytotoxicity of Hematite Nanoparticles in MRC-5 Cells.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2010English

Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib

Seminars in Hematology
Hematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy